Why the study?
Are increased endocannabinoid plasma levels associated with coronary circulatory dysfunction in obese individuals?
Are increased endocannabinoid plasma levels associated with coronary circulatory dysfunction in obese individuals?
Elevated endocannabinoid plasma levels may serve as a novel endogenous cardiovascular risk factor for coronary circulatory dysfunction in obesity.
May flag coronary dysfunction risk in obesity; hypothesis-generating and should not yet change practice.
Increased EC plasma levels of AEA and 2-AG are associated with coronary circulatory dysfunction in obese individuals. This observation might suggest increases in EC plasma levels as a novel endogenous cardiovascular risk factor in obesity, but needing further investigations.
No takes yet. Share an insight, caveat, or question.
Quercioli et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: